INTRODUCTION The particular epileptic conditions outlined in this chapter are very different from each other. However, they share a similar age of onset and the presence of…
INTRODUCTION Functional neuroimaging has contributed to the surgical management of epilepsy in two ways. First, functional imaging methods have facilitated decision making regarding the optimal placement of…
Since phenytoin was introduced for the treatment of epilepsy by Merritt and Putnam in 1938, it has become one of the most widely used and extensively investigated…
Selecting the appropriate dosage form and route of administration is a crucial, but underappreciated, component in the successful treatment of children with epilepsy. For example, some children…
INTRODUCTION The possible occurrence of myoclonic epilepsy in children with nonprogressive encephalopathy has been reported in the literature for many years by various authors (1–5). However, in…
As advocated by physicians and patient activist groups, the treatment goal for patients with epilepsy is to eliminate both seizures and adverse side effects of treatment (1)….
INTRODUCTION There are several forms of dietary treatment for epilepsy; arguably, the most important and effective is the ketogenic diet (KD). It is a high-fat, low-carbohydrate, and…
Experimental studies in diverse preparations, including brain slices and whole animals, have led to the view that the generation of focal epileptic activity represents an imbalance between…
INTRODUCTION The subgroup of generalized epilepsies which previously was known as idiopathic is now suggested to be termed genetic (1). These changes are part of those proposed…
Zonisamide (ZNS) was first synthesized by Dainippon Pharmaceutical Company in Osaka, Japan, in 1974 (1). ZNS was originally developed in an effort to discover medications for psychiatric…
